SCHEMBL25804330

SCHEMBL25804330

Nc1ncnn2c([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)ccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.51
▸ FBP1 P09467 2/20 0.48
▸ DNPH1 O43598 1/20 0.48
▸ PRKAB2 O43741 1/20 0.48
▸ TRPM2 O94759 1/20 0.48
▸ LDHA P00338 1/20 0.48
▸ ADRB2 P07550 1/20 0.48
▸ SRC P12931 1/20 0.48
▸ ADORA1 P30542 1/20 0.48
▸ P2RY2 P41231 1/20 0.48
▸ P2RY1 P47900 1/20 0.48
▸ PRKAG1 P54619 1/20 0.48
▸ PRKAA2 P54646 1/20 0.48
▸ PDE4D Q08499 1/20 0.48
▸ KCNH2 Q12809 1/20 0.48
▸ PRKAA1 Q13131 1/20 0.48
▸ PDE3A Q14432 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ TAS1R3 Q7RTX0 1/20 0.48
▸ TAS1R1 Q7RTX1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24538808 0.92 POLRMT (0.47) POLRMTFBP1DNPH1PRKAB2TRPM2
SCHEMBL10153839 0.90 POLRMT (0.61) POLRMTSRCP2RY2P2RY1SMN1; SMN2
SCHEMBL23042806 0.90 NT5E (0.52) POLRMTP2RY11
SCHEMBL16479517 0.82 POLRMT (0.59) POLRMTSRCP2RY2P2RY1SMN1; SMN2
SCHEMBL806950 0.82 POLRMT (0.59) POLRMTSRCP2RY2P2RY1SMN1; SMN2
SCHEMBL24982409 0.82 HIF1A (0.46) POLRMTADORA1SMN1; SMN2
SCHEMBL19101808 0.82 HIF1A (0.46) POLRMTADORA1SMN1; SMN2
SCHEMBL24982322 0.82 HIF1A (0.46) POLRMTADORA1SMN1; SMN2
SCHEMBL25008855 0.82 HIF1A (0.46) POLRMTADORA1SMN1; SMN2
SCHEMBL10154369 0.82 HIF1A (0.46) POLRMTADORA1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701372-B2 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs GILEAD SCIENCES, INC. (US) 2023-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11701372-B2 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs SLC29A1, SLC28A1, SLC29A2 POLRMT 75/4885FBP1 1564/4885DNPH1 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback